🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
Despite advances in medications, allergic diseases, including allergic asth...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-01
Trial ID
NCT01711593
Treatments Being Tested
This study uses an unconventional radiotherapy schedule developed at our in...
Status
Terminated
Location
KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Start Date
2018-10-30
Trial ID
NCT04168320
Treatments Being Tested
Study on the therapeutic effect of different infusion times on tislelizumab...
Status
Recruiting
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China
Start Date
2025-12-01
Trial ID
NCT07243691
Treatments Being Tested
RATIONALE: Cyclosporine may improve low blood counts caused by hematologic ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-03
Trial ID
NCT00031980
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This is a single-arm, open label, phase 1 study in subjects with beta-thala...
Status
Recruiting
Location
Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University
Start Date
2024-10-01
Trial ID
NCT06734520
Treatments Being Tested